Status:
ACTIVE_NOT_RECRUITING
Therapy for People With Opioid Use Disorder
Lead Sponsor:
Philadelphia College of Osteopathic Medicine
Collaborating Sponsors:
Prevention Point Philadelphia
Conditions:
Opioid Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this pilot clinical trial is to test the feasibility of a 12-week manualized cognitive-behavioral therapy treatment for opioid use disorder in reducing or stopping illicit opioid use in a ...
Detailed Description
Cognitive-Behavioral Therapy (CBT) is one of the most well-supported and widely used psychosocial treatments for substance use disorders (SUDs); however, few studies have evaluated the efficacy of CBT...
Eligibility Criteria
Inclusion
- Patient at Prevention Point Philadelphia
- 18 years or older
- Living with opioid use disorder
- Has a goal to reduce or eliminate illicit opioid use
- Able to provide informed consent
Exclusion
- Not comfortable receiving psychotherapy in English
- Under custodial supervision through the legal justice system (e.g., halfway house following incarceration, involuntary detention or confinement, status as a "prisoner")
Key Trial Info
Start Date :
August 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06008769
Start Date
August 6 2023
End Date
August 1 2024
Last Update
June 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prevention Point Philadelphia
Philadelphia, Pennsylvania, United States, 19134